Tokalas is a biotechnology company focused on developing novel drugs to treat orphan/rare diseases in oncology. The company is first targeting Ewing's Sarcoma, a rare bone cancer that affects primarily children and adolescents. Potential follow-on indications include subsets of glioblastoma (GBM) and acute myeloid leukemia (AML).

<